Biosimilars as Effective as Originator Biologics in IBD : co

In a systematic review, outcomes such as remission and loss of response were similar between patients with IBD who continued their original biologic and those who switched to a biosimilar.

Related Keywords

Canada , United Kingdom , Quebec , Vancouver , British Columbia , Chicago , Illinois , United States , British , Canadian , John Marshall , Stephenb Hanauer , Susanna Meade , Northwestern University Feinberg School Of Medicine , Health Canada , Journal Of The Canadian Association Gastroenterology , Canadian Association Of Gastroenterology , University Of British Columbia , Mcmaster University , Canadian Association , Colitis Canada , New Brunswick , Northwestern University Feinberg School , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Bd , Biologic Therapy , Biosimilars , Biosimilar Drugs , Follow On Biologics , Remission ,